Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma
Clinical trial NCT00404248 · COMPLETED
Trial details
- NCT number
- NCT00404248
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2009-06-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.